private:predxionbio
|
10481343
|
Dec 7th, 2023 12:00AM
|
Refractal
|
320
|
2.00
|
Open
|
|
Dec 7th, 2023 05:02AM
|
Dec 7th, 2023 05:02AM
|
PreDxion Bio is an early-stage healthcare company based in South San Francisco that is developing a highly scalable sensor platform (10M+ tests/day) to detect viruses and proteins, with particular emphasis on SARS-CoV-2 and biomarkers (immune markers). PreDxion Bio is backed by Y Combinator, Invest Detroit, and angel investors, and has received funding from the NIH. PreDxion Bio has been granted an FDA Breakthrough Device Designation for the development of our core localized surface plasmon resonance (LSPR) biosensor technology.
|
Open
|
Precision Medicine, Critical Care, and Immunomodulation
|
Open
|
329 Oyster Point Blvd
|
South San Francisco
|
California
|
US
|
94080
|
|
PreDxion Bio
|
|
|
private:predxionbio
|
10481343
|
Dec 6th, 2023 12:00AM
|
Refractal
|
320
|
2.00
|
Open
|
|
Dec 6th, 2023 05:13AM
|
Dec 6th, 2023 04:05PM
|
PreDxion Bio is an early-stage healthcare company based in South San Francisco that is developing a highly scalable sensor platform (10M+ tests/day) to detect viruses and proteins, with particular emphasis on SARS-CoV-2 and biomarkers (immune markers). PreDxion Bio is backed by Y Combinator, Invest Detroit, and angel investors, and has received funding from the NIH. PreDxion Bio has been granted an FDA Breakthrough Device Designation for the development of our core localized surface plasmon resonance (LSPR) biosensor technology.
|
Open
|
Precision Medicine, Critical Care, and Immunomodulation
|
Open
|
329 Oyster Point Blvd
|
South San Francisco
|
California
|
US
|
94080
|
|
PreDxion Bio
|
|
|
private:predxionbio
|
10481343
|
Dec 5th, 2023 12:00AM
|
Refractal
|
320
|
2.00
|
Open
|
|
Dec 5th, 2023 04:55AM
|
Dec 5th, 2023 04:10PM
|
PreDxion Bio is an early-stage healthcare company based in South San Francisco that is developing a highly scalable sensor platform (10M+ tests/day) to detect viruses and proteins, with particular emphasis on SARS-CoV-2 and biomarkers (immune markers). PreDxion Bio is backed by Y Combinator, Invest Detroit, and angel investors, and has received funding from the NIH. PreDxion Bio has been granted an FDA Breakthrough Device Designation for the development of our core localized surface plasmon resonance (LSPR) biosensor technology.
|
Open
|
Precision Medicine, Critical Care, and Immunomodulation
|
Open
|
329 Oyster Point Blvd
|
South San Francisco
|
California
|
US
|
94080
|
|
PreDxion Bio
|
|
|
private:predxionbio
|
10481343
|
Dec 4th, 2023 12:00AM
|
Refractal
|
320
|
2.00
|
Open
|
|
Dec 4th, 2023 02:58AM
|
Dec 4th, 2023 02:28PM
|
PreDxion Bio is an early-stage healthcare company based in South San Francisco that is developing a highly scalable sensor platform (10M+ tests/day) to detect viruses and proteins, with particular emphasis on SARS-CoV-2 and biomarkers (immune markers). PreDxion Bio is backed by Y Combinator, Invest Detroit, and angel investors, and has received funding from the NIH. PreDxion Bio has been granted an FDA Breakthrough Device Designation for the development of our core localized surface plasmon resonance (LSPR) biosensor technology.
|
Open
|
Precision Medicine, Critical Care, and Immunomodulation
|
Open
|
329 Oyster Point Blvd
|
South San Francisco
|
California
|
US
|
94080
|
|
PreDxion Bio
|
|
|
private:predxionbio
|
10481343
|
Dec 3rd, 2023 12:00AM
|
Refractal
|
320
|
2.00
|
Open
|
|
Dec 3rd, 2023 08:29AM
|
Dec 3rd, 2023 08:29AM
|
PreDxion Bio is an early-stage healthcare company based in South San Francisco that is developing a highly scalable sensor platform (10M+ tests/day) to detect viruses and proteins, with particular emphasis on SARS-CoV-2 and biomarkers (immune markers). PreDxion Bio is backed by Y Combinator, Invest Detroit, and angel investors, and has received funding from the NIH. PreDxion Bio has been granted an FDA Breakthrough Device Designation for the development of our core localized surface plasmon resonance (LSPR) biosensor technology.
|
Open
|
Precision Medicine, Critical Care, and Immunomodulation
|
Open
|
329 Oyster Point Blvd
|
South San Francisco
|
California
|
US
|
94080
|
|
PreDxion Bio
|
|
|
private:predxionbio
|
10481343
|
Dec 2nd, 2023 12:00AM
|
Refractal
|
320
|
2.00
|
Open
|
|
Dec 2nd, 2023 05:57AM
|
Dec 2nd, 2023 05:57AM
|
PreDxion Bio is an early-stage healthcare company based in South San Francisco that is developing a highly scalable sensor platform (10M+ tests/day) to detect viruses and proteins, with particular emphasis on SARS-CoV-2 and biomarkers (immune markers). PreDxion Bio is backed by Y Combinator, Invest Detroit, and angel investors, and has received funding from the NIH. PreDxion Bio has been granted an FDA Breakthrough Device Designation for the development of our core localized surface plasmon resonance (LSPR) biosensor technology.
|
Open
|
Precision Medicine, Critical Care, and Immunomodulation
|
Open
|
329 Oyster Point Blvd
|
South San Francisco
|
California
|
US
|
94080
|
|
PreDxion Bio
|
|
|
private:predxionbio
|
10481343
|
Dec 1st, 2023 12:00AM
|
Refractal
|
320
|
2.00
|
Open
|
|
Dec 1st, 2023 08:44AM
|
Dec 1st, 2023 05:06PM
|
PreDxion Bio is an early-stage healthcare company based in South San Francisco that is developing a highly scalable sensor platform (10M+ tests/day) to detect viruses and proteins, with particular emphasis on SARS-CoV-2 and biomarkers (immune markers). PreDxion Bio is backed by Y Combinator, Invest Detroit, and angel investors, and has received funding from the NIH. PreDxion Bio has been granted an FDA Breakthrough Device Designation for the development of our core localized surface plasmon resonance (LSPR) biosensor technology.
|
Open
|
Precision Medicine, Critical Care, and Immunomodulation
|
Open
|
329 Oyster Point Blvd
|
South San Francisco
|
California
|
US
|
94080
|
|
PreDxion Bio
|
|
|
private:predxionbio
|
10481343
|
Nov 30th, 2023 12:00AM
|
Refractal
|
320
|
2.00
|
Open
|
|
Nov 30th, 2023 05:30AM
|
Nov 30th, 2023 04:42PM
|
PreDxion Bio is an early-stage healthcare company based in South San Francisco that is developing a highly scalable sensor platform (10M+ tests/day) to detect viruses and proteins, with particular emphasis on SARS-CoV-2 and biomarkers (immune markers). PreDxion Bio is backed by Y Combinator, Invest Detroit, and angel investors, and has received funding from the NIH. PreDxion Bio has been granted an FDA Breakthrough Device Designation for the development of our core localized surface plasmon resonance (LSPR) biosensor technology.
|
Open
|
Precision Medicine, Critical Care, and Immunomodulation
|
Open
|
329 Oyster Point Blvd
|
South San Francisco
|
California
|
US
|
94080
|
|
PreDxion Bio
|
|
|
private:predxionbio
|
10481343
|
Nov 29th, 2023 12:00AM
|
Refractal
|
321
|
2.00
|
Open
|
|
Nov 29th, 2023 07:55AM
|
Nov 29th, 2023 07:55AM
|
PreDxion Bio is an early-stage healthcare company based in South San Francisco that is developing a highly scalable sensor platform (10M+ tests/day) to detect viruses and proteins, with particular emphasis on SARS-CoV-2 and biomarkers (immune markers). PreDxion Bio is backed by Y Combinator, Invest Detroit, and angel investors, and has received funding from the NIH. PreDxion Bio has been granted an FDA Breakthrough Device Designation for the development of our core localized surface plasmon resonance (LSPR) biosensor technology.
|
Open
|
Precision Medicine, Critical Care, and Immunomodulation
|
Open
|
329 Oyster Point Blvd
|
South San Francisco
|
California
|
US
|
94080
|
|
PreDxion Bio
|
|
|
private:predxionbio
|
10481343
|
Nov 28th, 2023 12:00AM
|
Refractal
|
321
|
2.00
|
Open
|
|
Nov 28th, 2023 05:28AM
|
Nov 28th, 2023 08:36PM
|
PreDxion Bio is an early-stage healthcare company based in South San Francisco that is developing a highly scalable sensor platform (10M+ tests/day) to detect viruses and proteins, with particular emphasis on SARS-CoV-2 and biomarkers (immune markers). PreDxion Bio is backed by Y Combinator, Invest Detroit, and angel investors, and has received funding from the NIH. PreDxion Bio has been granted an FDA Breakthrough Device Designation for the development of our core localized surface plasmon resonance (LSPR) biosensor technology.
|
Open
|
Precision Medicine, Critical Care, and Immunomodulation
|
Open
|
329 Oyster Point Blvd
|
South San Francisco
|
California
|
US
|
94080
|
|
PreDxion Bio
|
|
|